Latest News
UK housing market subdued in July as sales and enquiries falter
Housing activity in the UK disappointed in July, with both sales and enquiries seeing a continued lack of momentum, according to a new survey.
Commodities: Geopolitical tensions push gold higher
Gold saw a $10 move higher on Wednesday as tensions mounted between the US and North Korea over comments made by both sides.
FX round-up: Risk-off trade grips markets after Trump comments
Geopolitical tensions mounted on Wednesday after comments from Donald Trump, directed at North Korea, sent shockwaves across global markets.
Profits jump at Bushveld's Vametco Alloy on rising vanadium prices
Bushveld Minerals saw profits at part-owned Vametco Alloys shoot higher thanks to improved prices for vanadium, predicting prices would continue rising thanks to supply shortages.
Zamano close to finalising sale of business
Zamano, the Dublin-based internet and mobile technology company notified shareholders it believed it was close to clinching a sale of the business to a preferred party.
London close: Stocks pull-back amid troubling geopolitical headlines
London stocks stumbled on Wednesday as geopolitical tensions between North Korea and the international community came to a boil after another heated verbal exchange between the US and Pyongyang.
Share Centre parent company reports earnings ahead of expectations
Share, the parent company of popular retail stockbroker The Share Centre, announced it had seen a 23% increase in revenue over the first half to £8. 9m.
Europe close: Stocks down as investors play it safe
Shares ended near session lows following further provocative remarks out of Pyongyang which were quickly followed by a response from the US president.
Thursday preview: Prudential, DFS and TUI in focus
Thursday stands as the last big hurrah of results season, including numbers from Prudential, Glencore and DFS Furniture, and will see the only major UK macroeconomic data release of the week, in the form of industrial production and the trade balance.
FTSE 250 movers: Acacia leads the way as markets pull back on North Korea tensions
The FTSE 250 was down 0. 47% in afternoon trading against a backdrop of heightened geopolitical tensions caused by rising antagonism between the US and North Korea.
Adams puts new investment strategies on hold
Adams said it intends to table proposals regarding changes to its existing investment policy at its next annual general meeting.
US open: Investors go defensive
Wall Street is seeing slight losses on the back of continued negative newsflow out of the Far East, with Pyongyang having made a veiled threat of an attack against the US Pacific territory of Guam.
US pre-open: Wall Street set to fall on 10th anniversary of financial crisis
Stock futures are all pointing to a lower start on the tenth anniversary of the start of the global financial crisis after Washington and Pyongyang traded barbs overnight.
FTSE 100 movers: Gold miners higher as investors monitor North Korea headlines
Investors in precious metals miners' shares had a glint in their eye on Wednesday as Pyongang continued to make provocative remarks, with reports indicating the Hermit Kingdom was studying a possible missile strike against the US Pacific territory of Guam.
Tillerson calms North Korea panic, says there is no 'imminent threat'
US secretary of state Rex Tillerson has swiftly moved to declare there is 'no imminent threat of war' with North Korea after President Donald Trump promised to meet Pyongyang with 'fire and fury' on Tuesday.
WTI little changed despite big drop in weekly US oil stockpiles
US crude oil stockpiles fell last week as refineries ramped up production and imports declined.
Sherborne determined to continue activist focus on Electra
Activist investor Sherborne Investors said on Wednesday that its net asset value had fallen in the first six months of the year due to a drop in the share price of Electra Private Equity of which the firm holds a 29. 9% stake.
Last patient completes treatment in Motif Bio REVIVE-2 trial
Clinical stage biopharmaceutical company Motif Bio announced on Wednesday that the last patient had completed the treatment phase in REVIVE-2, its second Phase 3 clinical trial investigating the safety and efficacy of iclaprim in patients with acute bacterial skin and skin structure infections (ABSSSI).
Trading Emissions still awaiting cash from Italy solar sale
Trading Emissions updated the market on the sale of a further portion of its Italian solar portfolio to a member of the Sonnedix group on Wednesday, having initially announced the proposed transaction on 31 July.
US labor costs rise more slowly than expected in second quarter
US labor productivity picked up during the second quarter of 2017, helping to keep a lid on unit labor costs.